AbbVie, Shire Poised For M&A Battle As Tensions Flare
AbbVie Inc. made clear on Wednesday that it would keep chasing rival drugmaker Shire PLC even after the target rejected a $46 billion buyout bid, pulling from a playbook used by...To view the full article, register now.
Already a subscriber? Click here to view full article